A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease ...

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease ...

Elsa Mendoza has been living with the disease for years. Here's more on her battle and what it means to have Multiple ...

Exposure to common environmental chemicals, especially in combination, is linked to an increased risk of multiple sclerosis.

By analysing MRI scans and a simple blood test from hundreds of patients, researchers identified patterns that reveal how ...

WEDNESDAY, Dec. 17, 2025 (HealthDay News) — An over-the-counter supplement called lipoic acid might help slow the loss of gray matter in the brains of people with progressive multiple sclerosis (MS), ...

Clinicians and health system leaders met in Portland, Oregon, on October 21, 2025, to discuss the evolving options for treating Alzheimer disease and multiple sclerosis. The first speaker, Darla ...

Please provide your email address to receive an email when new articles are posted on . At week 96, treatment led to significant reductions in all exploratory MS-related biomarkers. Additional ...

MS Prodome Signs and Symptoms Can the Prodrome Be Diagnosed? MS Prodrome Progression to MS Biomarkers and the MS Prodrome Future Research Multiple sclerosis (MS) is a chronic autoimmune neurological ...

MS NOW sheds the last of its old MSNBC identity. MS NOW sheds the last of its old MSNBC identity. is a news writer covering all things consumer tech. Stevie started out at Laptop Mag writing news ...

MSNBC officially rebranded to MS NOW, which stands for My Source for News, Opinion and the World, on Saturday. The name change, which was announced in August, comes as the cable network moves to a new ...

Tyruko ® (natalizumab-sztn), a biosimilar to Tysabri ® (natalizumab), has been made available by Sandoz, according to developer Polpharma Biologics. Tyruko is an integrin receptor antagonist approved ...